Skip to main content

Day: February 8, 2024

Bel Fuse Schedules Fourth Quarter 2023 Financial Results Conference Call

WEST ORANGE, N.J., Feb. 08, 2024 (GLOBE NEWSWIRE) — Bel Fuse Inc. (Nasdaq: BELFA and BELFB), a designer, manufacturer, and provider of products that power, protect and connect electronic circuits, today announced plans to release preliminary financial results for the fourth quarter after market close on Wednesday, February 21, 2024. An earnings conference call has been scheduled as follows:When:   Thursday, February 22, 2024 at 8:30 a.m. ETDial in:   Toll free – 877.407.0784, or international – 201.689.8560Online:   https://ir.belfuse.com/events-and-presentationsHow:   Live over the internet – Simply log on to the web at the address aboveReplay:   844.512.2921, or international: 412.317.6671    Conference ID: 13743808 A replay will be available after 12:30 p.m. ET for 30 days following the call. About Bel...

Continue reading

Joint Stock Company “Latvijas Gāze” Extraordinary shareholders’ meetings of February 22, 2024 UPDATED DRAFT RESOLUTIONS

Joint Stock Company “Latvijas Gāze”Extraordinary shareholders’ meetings of February 22, 2024UPDATED DRAFT RESOLUTIONS (including the 12 candidates of members of the Supervisory Council to 11 Supervisory Council member positions and 3 candidates of the Audit Committee members to 3 the Audit Committee member positions proposed by shareholders) 1.On the Articles of Association of the Joint Stock Company “Latvijas Gāze” in the new wording and on the selection of the central securities depository in which to record the shares of the joint stock company “Latvijas Gāze” 1)To approve  the articles of association of the joint stock company “Latvijas Gāze”  in the new wording (annex). 2)To determine that dematerialized shares of the joint stock company “Latvijas Gāze” are to be recorded...

Continue reading

net2phone Unveils Global Connect

Enables multi-national businesses – whether using net2phone uContact, Microsoft Teams, or legacy platforms – to drop their local landlines by upgrading to a single-channel cloud connectivity solution Global Connect reduces connectivity costs substantially compared to legacy solutions while vastly simplifying the process of provisioning and administering voice connectivity Newark, NJ, Feb. 08, 2024 (GLOBE NEWSWIRE) — net2phone, a leading provider of intelligent communications-as-a-service for businesses and contact centers, today launched its Global Connect service. Global Connect provides multinational businesses with a single-channel, enterprise-grade cloud connectivity solution across multiple geographies. Organizations utilizing SIP trunks to connect their net2phone UContact CCaaS service, Microsoft Teams, or legacy on-premise...

Continue reading

PodcastOne Reports Revenue of $31.6M (+22% YoY) and Adjusted EBITDA* of $405K for First Nine Months Fiscal 2024

Revenue of $10.4M for Q3 Fiscal 2024 Successfully Closed an 8 figure Annual Revenue B2B partnership with a Fortune 500 company Ranked 10th in PODTRAC Top Publishers for January 2024 U.S. Unique Monthly Audience of ~5.3 million and Global Downloads and Streams of ~19.2 million 24 New Podcasts added in FY2024, with ~100 in the Pipeline and ~10 Acquisitions in the Pipeline Senior Management Will Host a Live Conference Call and Audio Webcast Beginning at 11:30 A.M. ET on Thursday, February 8, 2024LOS ANGELES, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — PodcastOne (Nasdaq: PODC), a leading podcast platform and a subsidiary of LiveOne (Nasdaq: LVO), which owns ~73% of the PODC outstanding common stock, announced today its operating results for the third fiscal quarter of its fiscal year ending March 31, 2024 (“Q3...

Continue reading

LiveOne (Nasdaq: LVO) Reports Q3 Fiscal Year 2024 Record Revenue of $31.2M and Adjusted EBITDA* of $3.3M, Memberships Increased 687K (+36% YoY)

Record Revenue of $87.5M and Adjusted EBITDA* of $8.2M for the First 9 Months FY 2024  Audio Division, consisting of Slacker Radio and PodcastOne (Nasdaq: PODC), Reports Record Revenue of $79.9M and Adjusted EBITDA* of $13M for First 9 Months FY 2024   Maintaining Guidance for FY 2025 Consolidated Revenue of $140M – $155M and Adjusted EBITDA* of $16M – $20M Maintaining Guidance for FY 2025 Audio Division of Revenues $130M – $140M and Adjusted EBITDA* of $20M – $25M and Over $17M of Positive Cash Flow LiveOne’s Senior Management Will Host a Live Conference Call and Audio Webcast Beginning at 10:00 A.M. ET on Thursday, February 8, 2024LOS ANGELES, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — LiveOne (Nasdaq: LVO), an award-winning, creator-first, music, entertainment, and technology platform,...

Continue reading

Ubiquitech Software Corp. (OTC: UBQU) Unveils Groundbreaking Lifestyle Video Marketing Initiative for Innovative Outcomes Driving Rapid Company Growth

DENVER, CO, Feb. 08, 2024 (GLOBE NEWSWIRE) — via NewMediaWire –Ubiquitech Software Corp. (OTC: UBQU) announces an additional strategic move towards acquiring Innovative Outcomes, Inc., a prominent player in the medical wound care sector. The company foresees unparalleled growth with a series of innovative marketing initiatives poised to transform the new partnership. Innovative Outcomes, Inc. is on the verge of completing its revolutionary “Lifestyle” video library, designed to educate healthcare professionals and patients about the Innovative Outcomes brand. The videos emphasize the significance of incorporating exercise, maintaining a balanced diet, and attending physician appointments into everyday life. Thus, promoting the Innovative Outcomes brand with potentially millions of patients and ready to deploy now. One...

Continue reading

Harfang Acquires 100% Interest in the Egan Gold Property

MONTREAL, Feb. 08, 2024 (GLOBE NEWSWIRE) — (TSX-V: HAR) (“Harfang” or the “Company”) is pleased to announce it has exercised its option to acquire 100% interest in the high-grade Egan Gold Property (“Egan” or the “Property”), subject to regulatory approvals. Highlights:Egan is strategically located in the heart of Ontario’s prolific Abitibi gold camp, central to mining operations in Timmins, Kirkland Lake, and Matachewan. Harfang has exercised its option to earn 100% interest in the Property in exchange for a combination of cash and shares. Exploration conducted by Harfang has generated several high-priority targets.“We are pleased to proceed with the acquisition of a 100% interest in Egan,” commented Rick Breger, President and CEO of Harfang. “From the beginning, it has delivered solid results from our exploration campaigns...

Continue reading

Replimune Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update

Positive data update in December 2023 for all 140 patients in the IGNYTE clinical trial cohort of RP1 in anti-PD1 failed melanoma demonstrating durability of response Centrally reviewed 12-month primary analysis data from IGNYTE trial of RP1 in anti-PD1 failed melanoma and biologics license application (BLA) submission expected in 2H 2024 Phase 3 confirmatory trial of RP1 in anti-PD1 failed melanoma skin cancers expected to initiate 2H 2024 Cash runway extended to fund operations into 2H 2026WOBURN, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced financial results for the fiscal third quarter ended December 31, 2023, and provided a business update. “The collective data...

Continue reading

Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patients

Biodexa Pharmaceuticals PLC Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patients CARDIFF, United Kingdom, February 8, 2024 (GLOBE NEWSWIRE) — Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs including Type 1 diabetes and rare/orphan brain cancers, today provided survival updates from its MAGIC-G1 study (NCT05324501) of MTX110 in patients with recurrent glioblastoma (“rGBM”) being conducted at Duke Cancer Institute and Baptist MD Anderson Cancer Center. In October 2023, Biodexa announced completion of recruitment of Cohort A of an ongoing open-label Phase I dose-escalation study designed to assess the feasibility and safety...

Continue reading

Rackspace Technology Appoints Experienced and Seasoned Executive Mark Gross to Board of Directors

Gross brings over 25 years of business experience and executive leadership to RackspaceRackspace Technology Appoints Experienced and Seasoned Executive Mark Gross to Board of DirectorsGross brings over 25 years of business experience and executive leadership to RackspaceSAN ANTONIO, Feb. 08, 2024 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT), a leading end-to-end hybrid, multicloud technology solutions company, today announced the appointment of Mark Gross to its Board of Directors. Gross is an experienced and dynamic leader with over 25 years of broad-based experience, financial expertise, and deep insight into leading business transformations. Gross succeeds Thomas Cole, who unexpectedly passed away over the recent holiday season. “We were fortunate to find Mark, a seasoned executive with financial expertise...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.